{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Pan X"],"funding":["National Natural Science Foundation of China"],"pagination":["100775"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8515245"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(1)"],"pubmed_abstract":["<h4>Background</h4>Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulatory infertility. Chinese herbal medicine (CHM) has many advantages in treating PCOS. We conducted a retrospective cohort study to investigate the effects of CHM (Bu-Shen-Tian-Jing Formula, BSTJF) on the outcomes of IVF in Chinese patients with PCOS and the potential underlying mechanism.<h4>Methods</h4>A total of 111 patients with PCOS who undergone IVF between November 2009 and July 2018 were included. Fifty-four patients received a three-month BSTJF therapy before controlled ovarian hyperstimulation, while the other 57 patients didn't. The data of the PCOS patients was collected. Anti-Müllerian hormone (AMH), growth differentiation factor-8 (GDF-8) levels in the follicular fluid were evaluated"],"journal":["Integrative medicine research"],"pubmed_title":["Chinese herbal medicine (Bu-Shen-Tian-Jing Formula) for outcomes of IVF in Chinese patients with polycystic ovary syndrome: a retrospective cohort study."],"pmcid":["PMC8515245"],"funding_grant_id":["81873837","82074476","81874480"],"pubmed_authors":["Pan X","Shi B","Gu Y","Cui L","Zhang X","Wang F","Qu F"],"additional_accession":[]},"is_claimable":false,"name":"Chinese herbal medicine (Bu-Shen-Tian-Jing Formula) for outcomes of IVF in Chinese patients with polycystic ovary syndrome: a retrospective cohort study.","description":"<h4>Background</h4>Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulatory infertility. Chinese herbal medicine (CHM) has many advantages in treating PCOS. We conducted a retrospective cohort study to investigate the effects of CHM (Bu-Shen-Tian-Jing Formula, BSTJF) on the outcomes of IVF in Chinese patients with PCOS and the potential underlying mechanism.<h4>Methods</h4>A total of 111 patients with PCOS who undergone IVF between November 2009 and July 2018 were included. Fifty-four patients received a three-month BSTJF therapy before controlled ovarian hyperstimulation, while the other 57 patients didn't. The data of the PCOS patients was collected. Anti-Müllerian hormone (AMH), growth differentiation factor-8 (GDF-8) levels in the follicular fluid were evaluated","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2025-04-04T09:40:14.57Z","creation":"2025-04-04T09:40:14.57Z"},"accession":"S-EPMC8515245","cross_references":{"pubmed":["34692411"],"doi":["10.1016/j.imr.2021.100775"]}}